[4r--(1alpha,5alpha,7beta)]-3-[(cycloprophylmethyl)hexahydro-5,6-dihydroxy-2-oxo-4,7-bis(phenylmethyl)-1h-1,3-diazepin]methyl-2-thiazolylbenzamide (846) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.105
Number of clusters 37
Number of clusters representing 95% 6
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 1.1621
ΔGstrain (kcal/mol) 0.2582
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 2173 0 3.0679
2 2153 0.0054 3.0305
3 1900 0.0795 3.0039
4 1682 0.1516 1.63
5 1405 0.2582 0.6117
6 385 1.0248 1.7668
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)